Player FM - Internet Radio Done Right
40 subscribers
Checked 4M ago
Tilføjet eight år siden
Konten disediakan oleh MediCom Oncology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh MediCom Oncology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !
Offline dengan aplikasi Player FM !
Podcast Layak Disimak
DISPONSORI
S
Squid Game: The Official Podcast
Squid Game is back, and so is Player 456. In the gripping Season 2 premiere, Player 456 returns with a vengeance, leading a covert manhunt for the Recruiter. Hosts Phil Yu and Kiera Please dive into Gi-hun’s transformation from victim to vigilante, the Recruiter’s twisted philosophy on fairness, and the dark experiments that continue to haunt the Squid Game. Plus, we touch on the new characters, the enduring trauma of old ones, and Phil and Kiera go head-to-head in a game of Ddakjji. Finally, our resident mortician, Lauren Bowser is back to drop more truth bombs on all things death. SPOILER ALERT! Make sure you watch Squid Game Season 2 Episode 1 before listening on. Let the new games begin! IG - @SquidGameNetflix X (f.k.a. Twitter) - @SquidGame Check out more from Phil Yu @angryasianman , Kiera Please @kieraplease and Lauren Bowser @thebitchinmortician on IG Listen to more from Netflix Podcasts . Squid Game: The Official Podcast is produced by Netflix and The Mash-Up Americans.…
CAR T case study in acute myeloid leukemia
Manage episode 218341036 series 1375096
Konten disediakan oleh MediCom Oncology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh MediCom Oncology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.
…
continue reading
53 episode
Manage episode 218341036 series 1375096
Konten disediakan oleh MediCom Oncology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh MediCom Oncology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.
…
continue reading
53 episode
Alle episoder
×1 Third-generation FLT3 inhibitors in clinical development 2:42
2:42
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:42Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.
1 CAR T case study in acute myeloid leukemia 5:49
5:49
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
5:49Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.
1 Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi 2:23
2:23
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:23Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.
1 How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance 3:58
3:58
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
3:58In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).
1 When to consider iron chelation therapy for a transplant-eligible patient 3:56
3:56
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
3:56Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.
1 53-year-old woman presenting with severe fatigue and bruising 3:58
3:58
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
3:58Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.
1 New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy 4:00
4:00
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
4:00Dr. O'Reilly discusses the new subcategories of pancreatic cancer that have emerged, and which are laying the groundwork for a biomarker-driven approach to therapy.
1 What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics? 2:40
2:40
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:40Dr. O'Reilly discusses the unique pathophysiology of pancreas cancer that must be considered in the development of novel therapeutics.
1 Predictors of response to lenalidomide in a non-del(5q) MDS patient 3:03
3:03
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
3:03Listen as Dr. Goldberg discusses, in just under two minutes, the predictors of response to lenalidomide in a non-del(5q) MDS patient.
1 What are the pros and cons of radiation therapy? 2:29
2:29
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:29Listen as Dr. Matasar discusses the pros and cons of radiation therapy, and who should be offered this therapy.
1 What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma? 3:01
3:01
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
3:01Listen as Dr. Matasar discusses survivorship care for patients who have been treated for classical Hodgkin lymphoma, including late effects of treatment.
1 Second primary malignancies associated with lenalidomide maintenance 2:53
2:53
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:53Dr. Jacob Laubach discusses second primary malignancies associated with lenalidomide maintenance in the transplant and post-transplant setting.
1 Impact of consolidation therapy in patients post-transplant 3:09
3:09
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
3:09Dr. Laubach discusses the impact of consolidation therapy in patients post-transplant, referencing results of the CTN StaMINA trial.
1 Bortezomib as an alternate strategy for maintenance therapy. 2:32
2:32
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:32Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma.
1 What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma? 2:35
2:35
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai
2:35Listen as Dr. Matasar discusses the future role of brentuximab vedotin in patients with newly diagnosed classical Hodgkin lymphoma.
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.